Carr Financial Group’s Bristol-Myers Squibb BMY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q1
Sell
-4,643
Closed -$263K 179
2024
Q4
$263K Buy
4,643
+361
+8% +$20.2K 0.08% 159
2024
Q3
$222K Buy
+4,282
New +$201K 0.06% 181
2023
Q1
Sell
-2,827
Closed -$203K 171
2022
Q4
$203K Buy
+2,827
New +$213K 0.11% 160

Other funds holding BMY

Carr Financial Group's BMY Position: Q1 2025 in Review

Carr Financial Group sold out of Bristol-Myers Squibb (BMY) in Q1 2025, closing a stake of 4,643 shares — an estimated $263K sold.

Carr Financial Group first reported a position in BMY in Q4 2022 and held it in 3 quarters. The position peaked at $263K in Q4 2024. 2,477 funds tracked by Wall St. Rank hold BMY as of Q1 2025.

  • Carr Financial Group reported no remaining Bristol-Myers Squibb position as of Q1 2025 after selling out during the quarter.
  • Carr Financial Group sold 4,643 Bristol-Myers Squibb shares in Q1 2025, an estimated $263K.
  • Carr Financial Group first reported a position in Bristol-Myers Squibb in Q4 2022 and held it in 3 quarters.
  • Carr Financial Group's Bristol-Myers Squibb position peaked at $263K in Q4 2024.
  • 2,477 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q1 2025.

Based on Carr Financial Group's 13F filing for Q1 2025, filed 22 Apr 2025.